Skip to content
‹ Back to IndustriesHealthcare

TMC Vibration Control Contributes To Groundbreaking Cancer Research

TMC Vibration Control partners with Oregon Health and Science University to stabilize advanced microscopes used in cancer research, using active piezoelectric cancellation to eliminate environmental vibrations that compromise high-resolution imaging at the nanoscale.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from TMC Vibration Control on MarketScale.

· Vibration ControlMicroscopyCancer ResearchNanoimaging
Share

Key takeaways

01

Environmental vibrations from traffic, light rail, and streetcars can blur microscope images; active feedback control systems eliminate this interference.

02

Nanoscale imaging reveals cellular and tissue architecture essential for understanding cancer mechanisms and developing targeted treatments.

03

TMC's Stasis Active Piezoelectric Cancellation System achieves zero-vibration operation, enabling electron microscopes to perform at peak sensitivity and resolution.

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

TMC Vibration Control has partnered with the Oregon Health and Science University (OHSU) to help stabilize the advanced microscopes OHSU researchers use to study the nanobiology of cancer.

TMC’s technology is essential for high-resolution imaging and accurate scientific research. Vibrations in the environment, such as from traffic, can cause the imaging equipment to shake, which can lead to blurred or distorted images.

The ability to study cells and tissues at the nanoscale level is essential for understanding how they function and how diseases like cancer progress. Understanding these diseases could save millions of lives. In 2023, about 1.9 million new cancer cases are expected to be diagnosed in the U.S. alone. According to the World Health Organization, cancer is a leading cause of death around the world.

TMC Vibration Control is crucial in enabling researchers, like those at OHSU, to develop a deeper understanding of the molecular and cellular mechanisms of disease, ultimately leading to improved diagnosis, treatment, and prevention of diseases.

Some of the researchers at OHSU, including Claudia S. Lopez, Ph.D., Jessica Riesterer, Ph.D. and Dr. Joe W. Gray, Ph.D., and Mike Georgalis, the North American Sales Manager for TMC, explain more about how OHSU and TMC work together to enable the groundbreaking research needed to cure cancer.

Claudia, Jessica, Joe and Mike’s Thoughts:

Claudia: OHSU is Oregon Health and Science University. It’s an academic institution and also a big hospital that serves the Oregon community. At the same time, it has a big research component in the basic science and also in the translational field. Both the local OHSU multiscale Microscopy Core and the Pacific Northwest Cryo-EM Center share the same facility in the basement of the Robertson Life Science Building at OHSU. Access to those facilities is different. While the local facility is a fee for service, the NIH Center is at no cost for those, all of those users having approved projects.

Jessica: As a staff scientist, I assist a lot of the projects as part of the Knight Cancer Institute in looking at the nanobiology of cancer. There’s a big push to look at how cancer cells are organized with their architecture at the cellular level, and so we need the highest resolution in order to do that.

Joe: One of the opportunities with the technologies that we have is to be able to see with few nanometer resolution the features that make up these cells and tissues. The challenge here, of course, is to make these measurements using technologies that run over periods of days to generate the dataset.

Claudia: Having all these microscopes in a good environment is essential. These instruments are very sensitive to vibration, to noise, and to electromagnetic interference.

Jessica: Environmental noise has affected our data, especially in this building. We are surrounded by the light rail, the river, the streetcar. That all affects our imaging.

Claudia: All of our electron microscopes are installed over TMC tables, and that has proven to be essential to be able to operate these instruments at their highest performance possible.

Mike: OHSU deployed the Stasis Active Piezoelectric Cancellation System, which contains sensors inside, which monitor the state of the system, and through active feedback control, they operate piezoelectric actuators, which expand and contract, essentially equally and opposite to the vibration that’s sensed.

Claudia: TMC has helped us mitigate all the vibrations that we have in this facility. On the TMC tables, we are at zero vibrations, which is essential for especially the high-end instruments that we have in the facility.

Jessica: TMC’s vibration control has allowed us to image at the highest resolution, including the nanoscale, and without that, we’d have skewed data.

Joe: We have finally gotten to the point in measurement science that we are able to define the components in the organizations of cells and tissues, and I think it’s going to give us a lot of insight as to how the components work together to actually produce the functions that we observe in the cells and tissues that we look at in the light microscope. So it’s an exciting time, lots to learn, a lot of challenges in terms of interpreting the data, but the measurement tools are there, and I think it’s going to be fun to watch how the field evolves.

Jessica: Cancer affects everyone. Everyone knows someone who’s had it or has it, and to be able to stop that for both the patient and for their loved ones would be life-changing.

Mike: What makes me proud about being at TMC and partnering with organizations like OHSU is that we get to be a small part of the groundbreaking research that’s being performed by Claudia and her colleagues that really has the potential to make an impact on a larger scale.

TMC Vibration Control

Part of this channel

TMC Vibration Control

Precision Instruments and Electromechanical Devices

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

LeanTaaS buys LookDeep Health and brings computer vision into hospital patient rooms

LeanTaaS buys LookDeep Health and brings computer vision into hospital patient rooms

LeanTaaS said on November 3 it acquired LookDeep Health, a computer vision company, and introduced iQueue for Virtual Care, its first product built on what it calls ambient intelligence. Terms were not disclosed. The product bundles Virtual Observation, Virtual Nursing and Virtual Medicine, and LeanTaaS says hospitals can build on compatible cameras and in-room devices already installed or deploy supported hardware. The company cited reported results from LookDeep deployments, including fall-rate reductions of more than 70%, and said LookDeep's technology was evaluated in peer-reviewed research published in Frontiers in Imaging.

  • 01LeanTaaS acquired LookDeep Health and launched iQueue for Virtual Care, combining Virtual Observation, Virtual Nursing and Virtual Medicine; acquisition terms were not disclosed.
  • 02Hospitals can build on compatible cameras and in-room devices already in place or deploy supported hardware, according to LeanTaaS, which did not name camera vendors.
  • 03LeanTaaS reported results from LookDeep deployments including fall-rate reductions of more than 70% and twice as much nursing contact, figures that are the company's own and not tied to named health systems.

Nov 3, 2026

Philips posts 8% order intake growth in Q3 and books a EUR 288 million Respironics provision

Philips posts 8% order intake growth in Q3 and books a EUR 288 million Respironics provision

Royal Philips reported 8% comparable order intake growth for the third quarter of 2026, driven by Diagnosis & Treatment, with comparable sales up 3% to EUR 4.4 billion and an adjusted EBITA margin of 13.0%, up 70 basis points. The company reiterated its 2026 outlook for 3% to 4.5% comparable sales growth. Philips Respironics reached an agreement in principle with the US Department of Justice to resolve previously disclosed investigations related to its recall, and Philips recorded a EUR 288 million provision in the quarter, with payment expected in the first quarter of 2027 subject to final documentation.

  • 01Comparable order intake grew 8%, matching a year earlier, with Diagnosis & Treatment the driver; the equipment order book stands at about 40% of revenue.
  • 02Comparable sales rose 3% to EUR 4.4 billion, adjusted EBITA margin reached 13.0%, and free cash flow was EUR 384 million; the 2026 outlook was reiterated.
  • 03Philips Respironics reached an agreement in principle with the DOJ on previously disclosed recall investigations, and Philips recorded a EUR 288 million provision; the settlement is subject to final documentation.

Nov 3, 2026

Rockwell Medical agrees to buy most of Vantive's hemodialysis business for $125 million

Rockwell Medical agrees to buy most of Vantive's hemodialysis business for $125 million

Rockwell Medical agreed to acquire most of Vantive's hemodialysis business for $125 million in base consideration, plus up to $45 million in contingent payments, with closing expected mid-2027. The deal includes hemodialysis concentrates, machines, water treatment systems, and Vantive's Medolla, Italy manufacturing facility; the combined business could generate $400-450 million annually, depending on various factors.

  • 01Rockwell Medical acquires Vantive's hemodialysis concentrates, AK 98 machines, water treatment systems, and one-million-square-foot Medolla, Italy manufacturing campus for $125 million base price plus up to $45 million contingent on revenue and EBITDA milestones.
  • 02Combined business targeted to generate $400-450 million in annual revenue depending on operating performance, exchange rates, market conditions and integration.
  • 03Vantive's dialyzer portfolio, including Theranova dialyzer for expanded hemodialysis, remains with Vantive; the company will focus on home dialysis and critical care after divestiture.

Nov 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512